Literature DB >> 21079602

Ultrasensitive in situ visualization of active glucocerebrosidase molecules.

Martin D Witte1, Wouter W Kallemeijn, Jan Aten, Kah-Yee Li, Anneke Strijland, Wilma E Donker-Koopman, Adrianus M C H van den Nieuwendijk, Boris Bleijlevens, Gertjan Kramer, Bogdan I Florea, Berend Hooibrink, Carla E M Hollak, Roelof Ottenhoff, Rolf G Boot, Gijsbert A van der Marel, Herman S Overkleeft, Johannes M F G Aerts.   

Abstract

Deficiency of glucocerebrosidase (GBA) underlies Gaucher disease, a common lysosomal storage disorder. Carriership for Gaucher disease has recently been identified as major risk for parkinsonism. Presently, no method exists to visualize active GBA molecules in situ. We here report the design, synthesis and application of two fluorescent activity-based probes allowing highly specific labeling of active GBA molecules in vitro and in cultured cells and mice in vivo. Detection of in vitro labeled recombinant GBA on slab gels after electrophoresis is in the low attomolar range. Using cell or tissue lysates, we obtained exclusive labeling of GBA molecules. We present evidence from fluorescence-activated cell sorting analysis, fluorescence microscopy and pulse-chase experiments of highly efficient labeling of GBA molecules in intact cells as well as tissues of mice. In addition, we illustrate the use of the fluorescent probes to study inhibitors and tentative chaperones in living cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21079602     DOI: 10.1038/nchembio.466

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  38 in total

1.  Imaging of enzyme replacement therapy using PET.

Authors:  Christopher P Phenix; Brian P Rempel; Karen Colobong; Doris J Doudet; Michael J Adam; Lorne A Clarke; Stephen G Withers
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease.

Authors:  Raquel L Lieberman; Brandon A Wustman; Pedro Huertas; Allan C Powe; Corey W Pine; Richie Khanna; Michael G Schlossmacher; Dagmar Ringe; Gregory A Petsko
Journal:  Nat Chem Biol       Date:  2006-12-24       Impact factor: 15.040

3.  The iminosugar isofagomine increases the activity of N370S mutant acid beta-glucosidase in Gaucher fibroblasts by several mechanisms.

Authors:  Richard A Steet; Stephen Chung; Brandon Wustman; Allan Powe; Hung Do; Stuart A Kornfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-31       Impact factor: 11.205

4.  A procedure for the rapid purification in high yield of human glucocerebrosidase using immunoaffinity chromatography with monoclonal antibodies.

Authors:  J M Aerts; W E Donker-Koopman; G J Murray; J A Barranger; J M Tager; A W Schram
Journal:  Anal Biochem       Date:  1986-05-01       Impact factor: 3.365

5.  Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease.

Authors:  R O Brady; J N Kanfer; R M Bradley; D Shapiro
Journal:  J Clin Invest       Date:  1966-07       Impact factor: 14.808

6.  Characterization of human glucocerebrosidase from different mutant alleles.

Authors:  T Ohashi; C M Hong; S Weiler; J M Tomich; J M Aerts; J M Tager; J A Barranger
Journal:  J Biol Chem       Date:  1991-02-25       Impact factor: 5.157

7.  Isofagomine induced stabilization of glucocerebrosidase.

Authors:  Gregory J Kornhaber; Michael B Tropak; Gustavo H Maegawa; Steven J Tuske; Stephen J Coales; Don J Mahuran; Yoshitomo Hamuro
Journal:  Chembiochem       Date:  2008-11-03       Impact factor: 3.164

8.  Clinical phenotype of Gaucher disease in relation to properties of mutant glucocerebrosidase in cultured fibroblasts.

Authors:  S Van Weely; M B Van Leeuwen; I D Jansen; M A De Bruijn; E M Brouwer-Kelder; A W Schram; M C Sa Miranda; J A Barranger; E M Petersen; J Goldblatt
Journal:  Biochim Biophys Acta       Date:  1991-06-05

9.  Chemical and biological approaches synergize to ameliorate protein-folding diseases.

Authors:  Ting-Wei Mu; Derrick Sek Tong Ong; Ya-Juan Wang; William E Balch; John R Yates; Laura Segatori; Jeffery W Kelly
Journal:  Cell       Date:  2008-09-05       Impact factor: 41.582

10.  N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis.

Authors:  F M Platt; G R Neises; R A Dwek; T D Butters
Journal:  J Biol Chem       Date:  1994-03-18       Impact factor: 5.157

View more
  74 in total

1.  Molecular probes: Getting lucky in the lysosome.

Authors:  Ethan D Goddard-Borger; Tom Wennekes; Stephen G Withers
Journal:  Nat Chem Biol       Date:  2010-12       Impact factor: 15.040

Review 2.  Current and Novel Aspects on the Non-lysosomal β-Glucosylceramidase GBA2.

Authors:  Aureli Massimo; Samarani Maura; Loberto Nicoletta; Mancini Giulia; Murdica Valentina; Chiricozzi Elena; Prinetti Alessandro; Bassi Rosaria; Sonnino Sandro
Journal:  Neurochem Res       Date:  2015-11-24       Impact factor: 3.996

3.  Profiling base excision repair glycosylases with synthesized transition state analogs.

Authors:  Aurea M Chu; James C Fettinger; Sheila S David
Journal:  Bioorg Med Chem Lett       Date:  2011-05-30       Impact factor: 2.823

4.  LIMP-2 expression is critical for β-glucocerebrosidase activity and α-synuclein clearance.

Authors:  Michelle Rothaug; Friederike Zunke; Joseph R Mazzulli; Michaela Schweizer; Hermann Altmeppen; Renate Lüllmann-Rauch; Wouter W Kallemeijn; Paulo Gaspar; Johannes M Aerts; Markus Glatzel; Paul Saftig; Dimitri Krainc; Michael Schwake; Judith Blanz
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-14       Impact factor: 11.205

5.  A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism.

Authors:  Elma Aflaki; Daniel K Borger; Nima Moaven; Barbara K Stubblefield; Steven A Rogers; Samarjit Patnaik; Frank J Schoenen; Wendy Westbroek; Wei Zheng; Patricia Sullivan; Hideji Fujiwara; Rohini Sidhu; Zayd M Khaliq; Grisel J Lopez; David S Goldstein; Daniel S Ory; Juan Marugan; Ellen Sidransky
Journal:  J Neurosci       Date:  2016-07-13       Impact factor: 6.167

6.  A sensitive gel-based method combining distinct cyclophellitol-based probes for the identification of acid/base residues in human retaining β-glucosidases.

Authors:  Wouter W Kallemeijn; Martin D Witte; Tineke M Voorn-Brouwer; Marthe T C Walvoort; Kah-Yee Li; Jeroen D C Codée; Gijsbert A van der Marel; Rolf G Boot; Herman S Overkleeft; Johannes M F G Aerts
Journal:  J Biol Chem       Date:  2014-10-24       Impact factor: 5.157

Review 7.  Small molecules as therapeutic agents for inborn errors of metabolism.

Authors:  Leslie Matalonga; Laura Gort; Antonia Ribes
Journal:  J Inherit Metab Dis       Date:  2016-12-13       Impact factor: 4.982

8.  Distinguishing the differences in β-glycosylceramidase folds, dynamics, and actions informs therapeutic uses.

Authors:  Fredj Ben Bdira; Marta Artola; Herman S Overkleeft; Marcellus Ubbink; Johannes M F G Aerts
Journal:  J Lipid Res       Date:  2018-10-02       Impact factor: 5.922

9.  Role of β-glucosidase 2 in aberrant glycosphingolipid metabolism: model of glucocerebrosidase deficiency in zebrafish.

Authors:  Lindsey T Lelieveld; Mina Mirzaian; Chi-Lin Kuo; Marta Artola; Maria J Ferraz; Remco E A Peter; Hisako Akiyama; Peter Greimel; Richard J B H N van den Berg; Herman S Overkleeft; Rolf G Boot; Annemarie H Meijer; Johannes M F G Aerts
Journal:  J Lipid Res       Date:  2019-09-27       Impact factor: 5.922

10.  Cell-permeable probe for identification and imaging of sialidases.

Authors:  Charng-Sheng Tsai; Hsin-Yung Yen; Meng-I Lin; Tsung-I Tsai; Shi-Yun Wang; Wen-I Huang; Tsui-Ling Hsu; Yih-Shyun E Cheng; Jim-Min Fang; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.